The bulk of loans from the July 6 Term ABS Loan Facility have gone to investors in legacy commercial MBS.

There’s nothing wrong with buying delinquent mortgages out of Ginnie pools, but some issuers may have been getting too greedy during the pandemic.

Federal regulators have delayed their review of risk-retention requirements until next year. Also, most regulatory actions planned for MBS and ABS fall into the “long-term” category.

The delinquency rate on commercial MBS could still be headed higher, but with smaller increases, according to industry experts.

Economists at the Federal Reserve Bank of New York found that having both to-be-announced and specified pools markets increase yields for MBS in both places.

The CRT market is showing signs of post-pandemic recovery. But Freddie Mac’s former CEO believes the re-proposed capital rule for the GSEs could make the whole CRT program pointless.

Under the CFPB proposal, which aims to establish a level playing field between the GSEs and the non-agency market, most loans will still be QMs, but there might be fewer incentives to sell the loans to the GSEs.

Nomura analyst Matthew Howlett says PennyMac's strong performance is a sign of boom times for mortgage lenders. He expects four or five IPOs of nonbank originators in the next nine to 12 months.

A COVID-19 infection in the Dallas office of document custodian BNY Mellon is causing MBS transactions to backup.

New Residential is coming to market with a security backed by Fannie Mae MSRs. As for the cost of the paper, details were sketchy.